Page last updated: 2024-11-07

3-(2,4-dihydroxyphenyl)propionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2,4-dihydroxyphenyl)propionic acid, also known as melilotic acid, is a naturally occurring organic compound found in various plants. It exhibits antioxidant and anti-inflammatory properties, making it a subject of interest for research in pharmacology and medicine. Studies have explored its potential therapeutic benefits in conditions such as diabetes, cardiovascular disease, and neurodegenerative disorders. Melilotic acid's antioxidant activity is attributed to its ability to scavenge free radicals and protect cells from oxidative damage. It is believed to exert its anti-inflammatory effects by inhibiting the production of pro-inflammatory mediators. The compound is typically synthesized via chemical reactions involving aromatic compounds and propionic acid derivatives.'
```

3-(2,4-dihydroxyphenyl)propionic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96384
CHEMBL ID228155
SCHEMBL ID490491
MeSH IDM0511093

Synonyms (39)

Synonym
NCIOPEN2_000618
5631-68-5
nsc71551
nsc-71551
2,4-dihydroxyhydrocinnamic acid
3-(2,4-dihydroxyphenyl)propanoic acid
3-(2,4-dihydroxyphenyl)propionic acid, >=95.0% (hplc)
propanoic acid, 3-(2,4-dihydroxyphenyl)-
2E7EBB5A-9F35-48AE-8361-557F93800936
hydroumbellic acid
AKOS000275820
3-(2,4-dihydroxyphenyl)propionic acid
STL034241
CHEMBL228155 ,
FT-0656366
F3228-0187
bdbm50211056
nsc 71551
ai3-13072
benzenepropanoic acid, 2,4-dihydroxy-
S3947
HMCMTJPPXSGYJY-UHFFFAOYSA-N
BBL028276
3-(2,4-dihydroxyphenyl) propionic acid
SCHEMBL490491
2,4-dihydroxybenzenepropanoic acid
DTXSID50204854
VU0606049-1
mfcd00143017
3_24_dihydroxyphenyl_propionic_acid
A869973
DS-5489
3-(2,4-dihydroxyphenyl)propionicacid
CCG-266449
I11543
HY-N1750
CS-0017426
EN300-37040
AB92943
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)1.85000.03403.987110.0000AID288281
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID288282Inhibition of mushroom tyrosinase at 0.5 uM for 10 min pre-incubated before addition of tyrosine2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency.
AID288284Inhibition of mushroom tyrosinase at 10 uM for 10 min pre-incubated before addition of tyrosine2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency.
AID288283Inhibition of mushroom tyrosinase at 0.3 uM for 10 min pre-incubated before addition of tyrosine2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency.
AID288281Inhibition of mushroom tyrosinase2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.62 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]